Search
MSK chemists are focusing on developing small-molecule drugs to target KRas, an important cancer protein.
A decade ago, the Sloan Kettering Institute embarked on an effort to broaden and streamline its research activities.
Scientists from Memorial Sloan Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.
Researchers are exploring a mysterious population of immune cells that live within tumors and can help the cancer grow and spread.
Researchers discover that a subset of lung adenocarcinomas are aggressive because of mutations that allow them to block ferroptosis, a type of cell death.
BCG has been used to treat bladder cancer for more than 30 years. Scientists are still learning how it works.
In October 2009, a team of eight researchers, six of whom are at Memorial Sloan Kettering, received an $11 million, five-year grant from the NCI to form one of 12 Physical Sciences-Oncology Centers (PS-OCs) in the United States.
A study led by researchers at Memorial Sloan Kettering Cancer Center has uncovered how breast tumors use a particular type of molecule to promote metastasis - the spread of cancer cells.
People with small amounts of brown fat have lower risk of certain obesity-related conditions, according to a retrospective study conducted by researchers at Memorial Sloan Kettering.
The online resource will serve as a benchmark for researchers studying metabolism and cancer.